Glepaglutide Reduces Need for Parenteral Support in Short Bowel Syndrome Trial
Positive topline results were announced from a phase 3 trial evaluating glepaglutide in patients with short bowel syndrome.
Home
Relyvrio, a New Treatment Option for ALS, Gets FDA Approval
Relyvrio is an oral, fixed-dose coformulation of sodium phenylbutyrate and taurursodiol.
Cemiplimab Offers Chemo-Free First-Line Option for Advanced NSCLC
First-line cemiplimab can improve long-term survival outcomes, compared with chemotherapy, in advanced non-small cell lung cancer.
Anticentromere Antibodies Can Serve as Diagnostic Marker for Sjögren Syndrome
A team of researchers from Japan studied the presence of Sjögren syndrome among patients with anticentromere antibodies.
Helmet May Be Better Than Facemask in CPAP for COVID-19 Respiratory Failure
How does use of a helmet vs facemask for CPAP affect rates of survival and intubation in patients with acute hypoxemic respiratory failure due to COVID-19?
Now Is the Time: Reconsider PSA Screening Guidelines
Over the past decade, there has been a profound increase in diagnoses of metastatic prostate cancer.
Clinical Challenge: Chest Pain, Shortness of Breath, and Nausea
A woman in her mid-40s presents to the emergency department with a history of nausea and pleuritic-like chest pain. Can you make the diagnosis?
Leniolisib Gets Priority Review for Activated Phosphoinositide 3-Kinase Delta Syndrome
Leniolisib is a small molecule inhibitor of the delta isoform of the 110 kDa catalytic subunit of class IA PI3K with immunomodulating and potentially antineoplastic activities.
Bevacizumab Biosimilar Vegzelma Gets FDA Approval
Vegzelma is a vascular endothelial growth factor inhibitor.
Iheezo Ophthalmic Gel Approved for Ocular Surface Anesthesia
Iheezo is a sterile, preservative-free, single-patient use, ophthalmic gel preparation.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Ophthalmology
Loading... 
Loading...